There is a threat of a lack of the drug Actilyse, which is used for the acute therapy of a cerebral infarction. The only business in the globe that marketplaces the drug is struggling with provide difficulties. “Hospitals are inspired to deal with their stocks responsibly,” says Robin Lemmens, neurologist at UZ Gasthuisberg in Leuven and vice president of the Belgian Stroke Council.
–
Related posts:
Is it true that the mutation of the new variant of COVID-19 can be reinfected and immune to vaccines...
Don't rush to take medicine, try drinking carrots and ginger to treat cholesterol
Shingles: Debunking 3 Common Misconceptions
"Sunlight" is dangerous for the body. Or how is it useful? | Hfocus.org Insights into the health ...
